Scott David Priebe

Array ( [id] => 7316382 [patent_doc_number] => 20040034880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Compound assay' [patent_app_type] => new [patent_app_number] => 10/638670 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6588 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034880.pdf [firstpage_image] =>[orig_patent_app_number] => 10638670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7236252 [patent_doc_number] => 20040073961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Nematode screening assay' [patent_app_type] => new [patent_app_number] => 10/634397 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16034 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20040073961.pdf [firstpage_image] =>[orig_patent_app_number] => 10634397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150041 [patent_doc_number] => 20040171158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Adenoviral vector incorporating zipper peptide-modified fiber protein and uses thereof' [patent_app_type] => new [patent_app_number] => 10/624218 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9248 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171158.pdf [firstpage_image] =>[orig_patent_app_number] => 10624218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116222 [patent_doc_number] => 20050069523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)' [patent_app_type] => utility [patent_app_number] => 10/614794 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8913 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069523.pdf [firstpage_image] =>[orig_patent_app_number] => 10614794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 530023 [patent_doc_number] => 07179646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => 'Gene expression using T cell factor responsive element' [patent_app_type] => utility [patent_app_number] => 10/607479 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 35 [patent_no_of_words] => 13090 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179646.pdf [firstpage_image] =>[orig_patent_app_number] => 10607479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351741 [patent_doc_number] => 20040048280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Promoters exhibiting endothelial cell specificity and methods of using same' [patent_app_type] => new [patent_app_number] => 10/416917 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 16416 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048280.pdf [firstpage_image] =>[orig_patent_app_number] => 10416917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6826480 [patent_doc_number] => 20030237102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Method of reducing neuronal electrical activity with a potassium channel subunit' [patent_app_type] => new [patent_app_number] => 10/438753 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12024 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20030237102.pdf [firstpage_image] =>[orig_patent_app_number] => 10438753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7377615 [patent_doc_number] => 20040220084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Methods for nucleic acid delivery' [patent_app_type] => new [patent_app_number] => 10/429660 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10806 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220084.pdf [firstpage_image] =>[orig_patent_app_number] => 10429660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639395 [patent_doc_number] => 20030212030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Novel adenoviral vector for transferring human genes in vivo' [patent_app_type] => new [patent_app_number] => 10/424996 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2113 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212030.pdf [firstpage_image] =>[orig_patent_app_number] => 10424996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623804 [patent_doc_number] => 07138512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Gene SHINC-2 and diagnostic and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 10/411931 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 22930 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138512.pdf [firstpage_image] =>[orig_patent_app_number] => 10411931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796370 [patent_doc_number] => 20030175243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Modified adenoviral fiber and target adenoviruses' [patent_app_type] => new [patent_app_number] => 10/402954 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10399 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175243.pdf [firstpage_image] =>[orig_patent_app_number] => 10402954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7424361 [patent_doc_number] => 20040208847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Method and vectors for selectively transducing retinal pigment epithelium cells' [patent_app_type] => new [patent_app_number] => 10/400531 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5871 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208847.pdf [firstpage_image] =>[orig_patent_app_number] => 10400531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850562 [patent_doc_number] => 20060233753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Use of adenoviruses mutated in the va genes for cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/509194 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6913 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233753.pdf [firstpage_image] =>[orig_patent_app_number] => 10509194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382770 [patent_doc_number] => 20040029227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Gene therapy' [patent_app_type] => new [patent_app_number] => 10/395287 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14368 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029227.pdf [firstpage_image] =>[orig_patent_app_number] => 10395287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378748 [patent_doc_number] => 20040028654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Protamine-adenoviral vector complexes and methods of use' [patent_app_type] => new [patent_app_number] => 10/391068 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 36649 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028654.pdf [firstpage_image] =>[orig_patent_app_number] => 10391068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821251 [patent_doc_number] => 20030219412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Somatic gene therapy to suppress secondary cataract formation following eye surgery' [patent_app_type] => new [patent_app_number] => 10/386330 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 8004 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219412.pdf [firstpage_image] =>[orig_patent_app_number] => 10386330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821249 [patent_doc_number] => 20030219410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Adenoviral vectors for modulating the cellular activities associated to PODs' [patent_app_type] => new [patent_app_number] => 10/355277 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23210 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219410.pdf [firstpage_image] =>[orig_patent_app_number] => 10355277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822086 [patent_doc_number] => 20030220247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Enhanced gamma-carboxylation of recombinant vitamin K-dependent clotting factors' [patent_app_type] => new [patent_app_number] => 10/349858 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10930 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220247.pdf [firstpage_image] =>[orig_patent_app_number] => 10349858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730096 [patent_doc_number] => 20030186286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans' [patent_app_type] => new [patent_app_number] => 10/334385 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11254 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186286.pdf [firstpage_image] =>[orig_patent_app_number] => 10334385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 650744 [patent_doc_number] => 07112321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-26 [patent_title] => 'Adeno-associated virus-mediated delivery of GDNF to skeletal muscles' [patent_app_type] => utility [patent_app_number] => 10/327620 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 19703 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112321.pdf [firstpage_image] =>[orig_patent_app_number] => 10327620 [rel_patent_id] =>[rel_patent_doc_number] =>)